Research team (IMAGE) The University of Hong Kong Caption Led by Professor Anskar Leung Yu-hung (centre), HKUMed’s Department of Medicine, School of Clinical Medicine, the research team has identified PLK4 as a novel therapeutic target for acute myeloid leukaemia carrying the TP53 mutation. Credit The University of Hong Kong Usage Restrictions N/A License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.